312
Participants
Start Date
September 23, 2016
Primary Completion Date
January 11, 2018
Study Completion Date
January 11, 2018
Bexagliflozin
Bexagliflozin tablet, 20 mg
Placebo
Placebo (inactive) tablet to match the active comparator
Research Site, The Bronx
Research Site, Dijon
Research Site, Madrid
Research Site, Madrid
Research Site, Alcalá de Henares
Research Site, Málaga
Research Site, Málaga
Research Site, Hollywood
Research Site, West Palm Beach
Research Site, Tampa
Research Site, Seville
Research Site, Paducah
Research Site, Stow
Research Site, Valencia
Research Site, Valencia
Research Site, Vénissieux
Research Site, Pierre-Bénite
Research Site, Oklahoma City
Research Site, Paris
Research Site, Paris
Research Site, Paris
Research Site, North Richland Hills
Research Site, San Antonio
Research Site, Round Rock
Research Site, Austin
Research Site, Austin
Research Site, Monument
Research Site, Poitiers
Research Site, La Palma
Research Site, San Dimas
Research Site, Riverside
Research Site, Fresno
Research Site, Lincoln
Research Site, Sacramento
Research Site, Norwalk
Research Site, Auburn
Research Site, Rockport
Research Site, Nashua
Research Site, Atsugi-shi
Research Site, Kamakura-shi
Research Site, Kawasaki-shi
Research Site, Yokohama
Research Site, Yokohama
Research Site, Yokohama
Research Site, Kyoto
Research Site, Kyoto
Research Site, Kawagoe-shi
Research Site, Kawaguchi-shi
Research site, Sayama-shi
Research Site, Hachioji-shi
Research Site, Hachioji-shi
Research Site, Minato-ku
Research Site, Ōta-ku
Research Site, Shinagawa-ku
Research Site, Toshima-ku
Research Site, Alicante
Lead Sponsor
Theracos
INDUSTRY